Loading insider details...
Beta
Latest Form 4 (Jun 11, 2026): Grant/Award of 37,000 NKTX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Nkarta, Inc. (NKTX) | Grant/Award | 37,000 | n/a |
| Jun 4, 2026 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 9,000 | n/a |
| Jan 8, 2026 | Zymeworks Inc. (ZYME) | Grant/Award | 459 | $4.8K |
| Jun 9, 2025 | Nkarta, Inc. (NKTX) | Grant/Award | 46,000 | n/a |
| Apr 11, 2025 | Kalaris Therapeutics, Inc. (KLRS) | Grant/Award | 18,000 | n/a |
| Jan 10, 2025 | Zymeworks Inc. (ZYME) | Grant/Award | 79,000 | n/a |
| Sep 3, 2024 | Zymeworks Inc. (ZYME) | Grant/Award | 360,000 | n/a |
| Jun 14, 2024 | Nkarta, Inc. (NKTX) | Grant/Award | 22,500 | n/a |
| Feb 28, 2024 | Tenaya Therapeutics, Inc. (TNYA) | Grant/Award | 35,000 | n/a |
| Feb 17, 2024 | Tenaya Therapeutics, Inc. (TNYA) | Sale | 5,201 | $30.5K |